Hindustan Bio Sciences Management Change
Hindustan Bio Sciences' Company Secretary and Compliance Officer Shailendra Vyas resigned, effective October 31, 2026. He cited an alternate career opportunity.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
9 announcements with these filters
Hindustan Bio Sciences' Company Secretary and Compliance Officer Shailendra Vyas resigned, effective October 31, 2026. He cited an alternate career opportunity.
Hindustan Bio Sciences Ltd reported revenue from operations of ₹0.8 Cr and net profit of ₹0.3 Cr for Q2 FY27.
Hindustan Bio Sciences Ltd intimated a board meeting on October 31, 2026 to consider unaudited financial results for the quarter ended September 30, 2026. The agenda items are proposed only; no results are yet approved.
Hindustan Bio Sciences Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, pursuant to SEBI Regulation 31(1)(b).
Hindustan Bio Sciences Ltd held its 34th Annual General Meeting on September 30, 2026. The meeting transacted business including adoption of financial statements and capital reduction.
Hindustan Bio Sciences Limited has issued a notice for its 34th Annual General Meeting to be held on September 30, 2026, in Hyderabad.
Hindustan Bio Sciences Ltd submitted its 34th Annual Report for FY 2025-26, containing the AGM notice proposing a scheme of capital reduction.
Hindustan Bio Sciences Ltd announced a capital reduction scheme to set off accumulated losses against its share capital. No cash consideration is paid to shareholders.
Hindustan Biosciences scheduled a board meeting for August 31, 2026, to discuss the 34th AGM notice and a proposed scheme of share capital reorganization.